Literature DB >> 12135542

Treatment non-response in OCD: methodological issues and operational definitions.

Stefano Pallanti1, Eric Hollander, Carol Bienstock, Lorrin Koran, James Leckman, Donatella Marazziti, Michele Pato, Dan Stein, Joseph Zohar.   

Abstract

While controlled trials with SRIs have demonstrated a selective efficacy in obsessive-compulsive disorder (OCD), up to 40-60% of patients do not have a satisfactory outcome. Non-response to treatment in OCD is associated with serious social disability. There are a large number of non-responsive patients, and they are difficult to cluster due to ambiguities in the diagnostic criteria, possibility of subtypes, and a high rate of comorbidity. Moreover, the findings of current studies of so-called 'non-responsive' cases are currently non-generalizable because of the lack of an operational definition of non-response. The result has been that a cumulative body of data on a reasonably homogeneous sample of non-responders has not been developed. The aims of this paper are to clarify some of the obstacles in defining stages of response and levels of non-response and, through a comprehensive analysis, to propose a systematic nosology for this rather common condition. Better characterization of which patients respond and do not respond to various treatments will enable more accurate clustering of patients, and help facilitate multi-site data collection for future research trials.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12135542     DOI: 10.1017/S1461145702002900

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  67 in total

Review 1.  A 2012 evidence-based algorithm for the pharmacotherapy for obsessive-compulsive disorder.

Authors:  Dan J Stein; Nastassja Koen; Naomi Fineberg; Leonardo F Fontenelle; Hisato Matsunaga; David Osser; H Blair Simpson
Journal:  Curr Psychiatry Rep       Date:  2012-06       Impact factor: 5.285

2.  Towards an international expert consensus for defining treatment response, remission, recovery and relapse in obsessive-compulsive disorder.

Authors:  David Mataix-Cols; Lorena Fernández de la Cruz; Ashley E Nordsletten; Fabian Lenhard; Kayoko Isomura; Helen Blair Simpson
Journal:  World Psychiatry       Date:  2016-02       Impact factor: 49.548

3.  Basolateral amygdala-ventromedial prefrontal cortex connectivity predicts cognitive behavioural therapy outcome in adults with obsessive-compulsive disorder.

Authors:  Miquel A Fullana; Xi Zhu; Pino Alonso; Narcís Cardoner; Eva Real; Clara López-Solà; Cinto Segalàs; Marta Subirà; Hanga Galfalvy; José M Menchón; H Blair Simpson; Rachel Marsh; Carles Soriano-Mas
Journal:  J Psychiatry Neurosci       Date:  2017-11       Impact factor: 6.186

4.  N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder.

Authors:  Daniel L Lafleur; Christopher Pittenger; Ben Kelmendi; Tom Gardner; Suzanne Wasylink; Robert T Malison; Gerard Sanacora; John H Krystal; Vladimir Coric
Journal:  Psychopharmacology (Berl)       Date:  2005-12-22       Impact factor: 4.530

5.  Paroxetine treatment of compulsive hoarding.

Authors:  Sanjaya Saxena; Arthur L Brody; Karron M Maidment; Lewis R Baxter
Journal:  J Psychiatr Res       Date:  2006-06-21       Impact factor: 4.791

6.  Escitalopram in obsessive-compulsive disorder: a case series.

Authors:  Amit Zutshi; Suresh Bada Math; Y C Janardhan Reddy
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

7.  Ondansetron augmentation in treatment-resistant obsessive-compulsive disorder: a preliminary, single-blind, prospective study.

Authors:  Stefano Pallanti; Silvia Bernardi; Sarah Antonini; Nikhilesh Singh; Eric Hollander
Journal:  CNS Drugs       Date:  2009-12       Impact factor: 5.749

8.  Augmentation effect of repetitive transcranial magnetic stimulation over the orbitofrontal cortex in drug-resistant obsessive-compulsive disorder patients: a controlled investigation.

Authors:  Chiara Ruffini; Marco Locatelli; Adelio Lucca; Francesco Benedetti; Chiara Insacco; Enrico Smeraldi
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

9.  Long-term outcome in adults with obsessive-compulsive disorder.

Authors:  Michael H Bloch; Christy Green; Stephen A Kichuk; Philip A Dombrowski; Suzanne Wasylink; Eileen Billingslea; Angeli Landeros-Weisenberger; Benjamin Kelmendi; Wayne K Goodman; James F Leckman; Vladimir Coric; Christopher Pittenger
Journal:  Depress Anxiety       Date:  2013-03-26       Impact factor: 6.505

10.  Current trends in drug treatment of obsessive-compulsive disorder.

Authors:  Eric H Decloedt; Dan J Stein
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-25       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.